Relative efficacy and safety of apremilast, secukinumab, and ustekinumab for the treatment of psoriatic arthritis
Crossref DOI link: https://doi.org/10.1007/s00393-017-0355-8
Published Online: 2017-08-08
Published Print: 2018-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Song, G. G.
Lee, Y. H.
License valid from 2017-08-08